Rahul Gandhi's interactions on COVID-19: Congress releases teaser of discussion with industrialist Rajiv Bajaj

In the teaser of the conversation released on various social media accounts of the party, Gandhi, citing experts, is seen talking about the fear of the coronavirus disease, which, if spreads once, is difficult to get rid of.

PTI

June 03, 2020 / 07:47 PM IST

live

bselive
nselive

Volume

Todays L/H

Rahul Gandhi's dialogue with industrialist Rajiv Bajaj on the economic fallout of the COVID-19 crisis will be aired on Thursday, the latest in the series of deliberations the former Congress chief is having with experts from various fields on the impact of the pandemic.

In the teaser of the conversation released on various social media accounts of the party, Gandhi, citing experts, is seen talking about the fear of the coronavirus disease, which, if spreads once, is difficult to get rid of.

In the teaser, Managing Director of Bajaj Auto, Rajiv Bajaj, is seen talking about the effect of the lockdown on the economy.

"The virus is waiting to hit you, so you have not solved that problem, but you have decimated the economy. You have flattened the wrong curve -- not the infection curve but the GDP curve. This is what we have ended with -- the worst of both worlds," Bajaj says.

Coronavirus India News LIVE Updates

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show